)
MeiraGTx Holdings (MGTX) investor relations material
MeiraGTx Holdings Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Clinical-stage genetic medicines company with late-stage programs in Parkinson's, xerostomia, and retinal dystrophy, and advanced pivotal Phase 2 and Phase 3 studies.
Internal end-to-end manufacturing capabilities and proprietary gene regulation platform.
Strategic collaborations with Hologen AI and Eli Lilly, including significant upfront and milestone payments, and joint ventures.
Acquisition of Smart Immune assets to expand cell therapy pipeline.
Completed optimization of riboswitch leptin program, with IND-enabling discussions ongoing.
Financial highlights
Net loss of $50.5M for Q3 2025, up from $39.3M in Q3 2024; net loss of $129.3M for nine months ended September 30, 2025.
Revenue of $0.4M for Q3 2025, down from $10.9M in Q3 2024; $6.0M for nine months, down from $11.9M year-over-year.
Cash, cash equivalents, and restricted cash of $17.1M as of September 30, 2025, down from $105.7M at December 31, 2024.
Operating expenses decreased to $46.5M in Q3 2025 from $51.0M in Q3 2024; $138.5M for nine months, down from $144.6M.
R&D expenses increased to $32.5M in Q3 2025 from $26.2M in Q3 2024, mainly due to higher manufacturing and clinical trial material costs.
Outlook and guidance
Anticipates sufficient funding into the second half of 2027, including repayment of $75M debt due August 2026, supported by upfront and milestone payments from Eli Lilly and Hologen AI.
Expects pivotal data for AAV-hAQP1 in early 2027, with potential BLA filing and approval later that year.
Expects continued operating losses and need for additional capital for product development and commercialization.
Plans to initiate Phase 3 AAV-GAD study for Parkinson's disease in the coming months.
Riboswitch leptin program expected to enter the clinic following IND-enabling discussions.
Next MeiraGTx Holdings earnings date
Next MeiraGTx Holdings earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage